Exoskeleton Market Growth: Lifeward & Shirley Ryan AbilityLab Drive Rehabilitation Innovation
Published: 13 Mar 2026
Author: Precedence Research
The exoskeleton industry is expected to grow steadily due to the rising demand for wearable robotics that improve mobility and safety. These systems boost human capability of strength, movement, and endurance by increasing adoption in the healthcare industry, defence, and other sectors.
Strategic investments by medical device manufacturers, with rising demand for post-injury mobility solutions, and increasing military funding for soldier-wearable robotics are reshaping the industry landscape. Integration of AI, real-time feedback systems, and sensor-based motion control has improved both usability and patient outcomes.
Lifeward LtdLifeward Ltd, a global leader in innovative medical technology, has the main purpose is to transform the lives of people with physical limitations or disabilities, in a joint effort with Shirley Ryan AbilityLab, a global leader in physical medicine and rehabilitation. This collaboration has to accelerate the evaluation and accessibility of the ReWalk Personal Exoskeleton.
According to Toward Healthcare, The Exoskeleton Market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 681.53 million in 2026 to approximately USD 2308.97 billion by 2035, representing a compound annual growth rate (CAGR) of 14.52% from 2026 to 2035. This market is evolving into a structural solution that addresses these systemic challenges rather than functioning as a discretionary tool.
About Shirley Ryan AbilityLab
Global leader in physical medicine and rehabilitation for adults and children with complex conditions from traumatic brain and spinal cord injury to stroke, amputation, and cancer-related impairment. It is the first-ever “translational” research rehabilitation hospital. It enables patients to have access to the brightest minds, the latest research, and the best opportunity for recovery.
About Lifeward
It features innovative products, including the ReWalk Exoskeleton, the AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle FES Systems. It drives innovation to change the lives of individuals with physical limitations or disabilities. It is committed to delivering ground-breaking solutions that empower individuals to do what they love.
Exoskeletons are increasingly integrated into rehabilitation therapy programs for stroke recovery, spinal cord injuries, and musculoskeletal disorders, owing to their ability to deliver consistent, repetitive motion that supports neural recovery.
A recent report by Toward Healthcare highlights that the Exoskeleton market is experiencing the adoption of robotic rehabilitation tools, which is being reinforced by positive clinical trial outcomes, increasing insurance coverage experimentation, and institutional investment in assistive technologies.